ChromaCode, Inc, a California-based company redefining molecular testing through data science, announced that it has raised a $10 million Series C extension with an investment from Adjuvant Capital. The Adjuvant investment brings the company’s total Series C funding to $38 million. Managing Partner Jenny Yip will join ChromaCode’s Board of Directors. Existing investors Northpond Ventures,…